Imatron posts record Q4 results

Article

Imatron, a South San Francisco, CA-based diagnostic imaging company that creates electron beam tomography heart scanners, posted the highest profits in the company’s history at the end of 1999. Imatron made a revenue gain of $7 million in 1999 over

Imatron, a South San Francisco, CA-based diagnostic imaging company that creates electron beam tomography heart scanners, posted the highest profits in the company’s history at the end of 1999. Imatron made a revenue gain of $7 million in 1999 over the previous year, netting $37.5 million compared to $30.7 million in 1998. Net loss was $6.6 million for the 1999 fiscal year, compared to a net loss of $14.8 million for the prior year. Revenues from continuing operations in the fourth quarter of 1999 increased by 58% to $12.9 million compared to revenues of $8.2 million for the fourth quarter of 1998.

These figures do not include business produced by HeartScan Imaging, a program that enabled customers to visit a clinic and receive a heart scan using the company’s Ultrafast CT scanners. Imatron sold this unprofitable subsidiary in November 1999.

The company attributes its financial high to selling a record seven scanners during the fourth quarter and 19 for the year. This is compared with sales of four scanners in the fourth quarter of 1998 and 15 for that year. In addition, the company increased its manufacturing capacity.

Imatron is confident sales will continue to surge because peer-reviewed journal articles support both coronary artery scanning and electron beam angiography, applications of the company’s proprietary electron beam tomography technology that were recently cleared by the FDA.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.